COOREMAN, MICHAEL P.,柯尔曼 米迦勒Ｐ,柯爾曼 米迦勒Ｐ,KIKKAWA, KOHEI,吉川公平,柯尔曼 米迦勒P,柯爾曼 米迦勒P
申请号：
TW106132944
公开号：
TW201817425A
申请日:
2017.09.26
申请国别(地区):
TW
年份:
2018
代理人:
摘要：
The present invention provides a pharmaceutical composition for prophylaxis and treatment of NAFLD comprising as an active ingredient a 1,4-benzoxazine compound represented by formula (I): or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, as well as a method for prophylaxis and treatment of NAFLD which comprises administering a therapeutically effective amount of the above-mentioned 1,4-benzoxazine compound represented by formula (I) and so on to a patient in need thereof.本發明提供用於預防與治療非酒精性脂肪肝疾病(NAFLD)之醫藥組成物，該醫藥組成物包含由式(I)表示之1,4-苯并化合物或其醫藥上可接受之鹽作為活性成分： ，及醫藥上可接受之載劑，以及用於預防與治療NAFLD之方法，該方法包含將治療上有效量之前述由式(I)表示之1,4-苯并化合物等投予有需要的患者。
